Support of rational pharmacotherapy and medical insurance companies – theory and practice

Česká verzia

Authors: M. Prokeš ¹; Z. Vitásek ²
Authors place of work: INFOPHARM, Praha ¹; ZPŠ, Praha ²
Published in the journal: Reviz. posud. Lék., 14, 2011, č. 4, s. 147-153

Summary

For the optimization of prescription it is useful to provide the physicians the feedback by means of prescription assessment. The assessment if based on a statistical processing of the prescription data, which is capable of identification of certain pharmacotherapy problems in individual physicians. The article presents well-arranged information about the support of rational pharmacotherapy, the way of intervention of health insurance companies and draws attention to some obstacles of such intervention.

Key words:
optimization of prescription – identification of pharmacotherapy problems – the support of rational pharmacotherapy – possibilities in intervention of medical insurance companies

Zdroje

1. Věstník MZ ČR 2009, částka 9, s. 5–9, dostupné na:

www.mzcr.cz.

2. http://www.happyaudit.org/files/pub/4398.pdf.

3. http://www.cls.cz/dokumenty/atb.doc.

4. http://www.cls.cz/dokumenty/dp_imc.doc.

5. http://app.esac.ua.ac.be/public/.

6. http://www.ecdc.europa.eu/en/activities/surveillance/EARS-Net/Pages/index.aspx.

7. Coenen. S., Ferech, M., Haaijer-Ruskamp, F. M. et al. European Surveillance of Antimicrobial Consumption (ESAC): quality indicators for outpatient antibiotic use in Europe. Qual. Saf. Health Care, 2007, 16, p. 440–445, dostupné na http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2653179/pdf/440.pdf.

8. Goosens, H., Ferech, M., Coenen, S. et al. Comparison of Outpatient Systemic Antibacterial Use in 2004 in the United States and 27 European Countries. Clin. Infect. Dis., 2007, 44, 8, p. 1091–1095, dostupné na

http://cid.oxfordjournals.org/content/44/8/1091.long.

9. Ferech, M., Coenen, S., Dvorakova, K. et al. European Surveillance of Antimicrobial Consumption (ESAC): outpatient penicillin use in Europe. J. Antimicrob. Chemother., 2006, 58, 2, p. 408–412, dostupné na:

http://jac.oxfordjournals.org/content/58/2/408.full.pdf+html.

10. Coenen, S., Ferech, M., Malhotra-Kumar, S. et al. European Surveillance of Antimicrobial Consumption (ESAC): outpatient macrolide, lincosamide and streptogramin (MLS) use in Europe. Journal of Antimicrobial Chemotherapy, 2006, 58, p. 418–422, dostupné na:

http://jac.oxfordjournals.org/content/58/2/418.full.pdf+html.

11. Coenen, S., Ferech, M., Malhotra-Kumar, S. et al. European Surveillance of Antimicrobial Consumption (ESAC): outpatient quinolone use in Europe. J. Antimicrob. Chemother., 2006, 58, 2, p. 423–427, dostupné na:

http://jac.oxfordjournals.org/content/58/2/423.full.pdf+html.

12. Prokeš, M. Němec, O.: Podpora účelného předepisování antibiotik: Je třeba zohlednit věk pacientů? Dostupné na:

http://www.drugagency.cz/prezentace.php?id=22.

13. Prokeš, M. Hodnocení kvality preskripce. Klin. Farmakol. Farm., 2008, 22, 3, p. 118–122, dostupné na:

http://www.solen.cz/pdfs/far/2008/03/08.pdf.